SARCOMA

Latest News

FDA Grants Elraglusib Orphan Drug Designation in Soft Tissue Sarcoma
FDA Grants Elraglusib Orphan Drug Designation in Soft Tissue Sarcoma

September 12th 2024

The FDA granted orphan drug designation for elraglusib, a novel drug for treating advanced soft tissue sarcoma.

FDA Grants Priority Review to Vimseltinib Application in Tenosynovial Giant Cell Tumor
FDA Grants Priority Review to Vimseltinib Application in Tenosynovial Giant Cell Tumor

August 16th 2024

Phase 1/2 Trial of Silmitasertib in Sarcoma and Brain Tumors to Proceed
Phase 1/2 Trial of Silmitasertib in Sarcoma and Brain Tumors to Proceed

August 8th 2024

FDA Clears SeCore CDx as Companion Diagnostic for Afami-cel in Synovial Sarcoma
FDA Clears SeCore CDx as Companion Diagnostic for Afami-cel in Synovial Sarcoma

August 7th 2024

Behind the FDA Approval: Afami-Cel in Synovial Sarcoma
Behind the FDA Approval: Afami-Cel in Synovial Sarcoma

August 2nd 2024